These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 10217313

  • 1. Formulation and biological activity of antineoplastic proteoglycans derived from Mycobacterium vaccae in chitosan nanoparticles.
    Tian XX, Groves MJ.
    J Pharm Pharmacol; 1999 Feb; 51(2):151-7. PubMed ID: 10217313
    [Abstract] [Full Text] [Related]

  • 2. Isolation and biological activities of an antineoplastic protein-polysaccharide complex (PS4A) obtained from Mycobacterium vaccae.
    Tian XX, Li A, Zhou W, Farrugia IV, Groves MJ.
    Anticancer Res; 1999 Feb; 19(1A):237-43. PubMed ID: 10226548
    [Abstract] [Full Text] [Related]

  • 3. Anticancer activity of mycobacterial DNA: effect of formulation as chitosan nanoparticles.
    Kabbaj M, Phillips NC.
    J Drug Target; 2001 Feb; 9(5):317-28. PubMed ID: 11770702
    [Abstract] [Full Text] [Related]

  • 4. Acute cardio-respiratory effects in rats of PS4alpha, an antineoplastic peptidoglycan from Mycobacterium vaccae.
    Villar VM, Morcillo EJ, Cortijo J, Reed A, Groves MJ.
    J Pharm Pharmacol; 2001 Jun; 53(6):907-9. PubMed ID: 11428669
    [Abstract] [Full Text] [Related]

  • 5. Initial characterization of an antineoplastic, polysaccharide-rich extract of Mycobacterium bovis BCG, Tice substrain.
    Lou Y, Klegerman ME, Muhammad A, Dai X, Groves MJ.
    Anticancer Res; 1994 Jun; 14(4A):1469-75. PubMed ID: 7979173
    [Abstract] [Full Text] [Related]

  • 6. Quaternized chitosan/alginate nanoparticles for protein delivery.
    Li T, Shi XW, Du YM, Tang YF.
    J Biomed Mater Res A; 2007 Nov; 83(2):383-90. PubMed ID: 17450586
    [Abstract] [Full Text] [Related]

  • 7. Optimization of physicochemical parameters influencing the fabrication of protein-loaded chitosan nanoparticles.
    Vandana M, Sahoo SK.
    Nanomedicine (Lond); 2009 Oct; 4(7):773-85. PubMed ID: 19839813
    [Abstract] [Full Text] [Related]

  • 8. Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics.
    Bozkir A, Saka OM.
    Drug Deliv; 2004 Oct; 11(2):107-12. PubMed ID: 15200009
    [Abstract] [Full Text] [Related]

  • 9. Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice.
    Maeda Y, Kimura Y.
    J Nutr; 2004 Apr; 134(4):945-50. PubMed ID: 15051852
    [Abstract] [Full Text] [Related]

  • 10. Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.
    Gan Q, Wang T.
    Colloids Surf B Biointerfaces; 2007 Sep 01; 59(1):24-34. PubMed ID: 17555948
    [Abstract] [Full Text] [Related]

  • 11. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
    Ishihara M, Obara K, Ishizuka T, Fujita M, Sato M, Masuoka K, Saito Y, Yura H, Matsui T, Hattori H, Kikuchi M, Kurita A.
    J Biomed Mater Res A; 2003 Mar 01; 64(3):551-9. PubMed ID: 12579570
    [Abstract] [Full Text] [Related]

  • 12. Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity.
    Yan C, Chen D, Gu J, Qin J.
    J Pharm Pharmacol; 2006 Sep 01; 58(9):1177-81. PubMed ID: 16945175
    [Abstract] [Full Text] [Related]

  • 13. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B, Somavarapu S, Li XW, Thanou M, Sesardic D, Alpar HO, Senel S.
    Int J Pharm; 2008 Nov 03; 363(1-2):139-48. PubMed ID: 18662762
    [Abstract] [Full Text] [Related]

  • 14. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
    Huang YC, Chiang CH, Yeh MK.
    J Microencapsul; 2003 Nov 03; 20(2):247-60. PubMed ID: 12554378
    [Abstract] [Full Text] [Related]

  • 15. Chitosan based micro- and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods.
    Cerchiara T, Abruzzo A, di Cagno M, Bigucci F, Bauer-Brandl A, Parolin C, Vitali B, Gallucci MC, Luppi B.
    Eur J Pharm Biopharm; 2015 May 03; 92():112-9. PubMed ID: 25769679
    [Abstract] [Full Text] [Related]

  • 16. Formulation pH modulates the interaction of insulin with chitosan nanoparticles.
    Ma Z, Yeoh HH, Lim LY.
    J Pharm Sci; 2002 Jun 03; 91(6):1396-404. PubMed ID: 12115839
    [Abstract] [Full Text] [Related]

  • 17. Nanoparticle formation by using shellac and chitosan for a protein delivery system.
    Kraisit P, Limmatvapirat S, Nunthanid J, Sriamornsak P, Luangtana-anan M.
    Pharm Dev Technol; 2013 Jun 03; 18(3):686-93. PubMed ID: 22568768
    [Abstract] [Full Text] [Related]

  • 18. Biological fate of highly-succinylated N-succinyl-chitosan and antitumor characteristics of its water-soluble conjugate with mitomycin C at i.v. and i.p. administration into tumor-bearing mice.
    Kato Y, Onishi H, Machida Y.
    Biol Pharm Bull; 2000 Dec 03; 23(12):1497-503. PubMed ID: 11145185
    [Abstract] [Full Text] [Related]

  • 19. Chitosan-stablized bovine serum albumin nanoparticles having ability to control the release of NELL-1 protein.
    Li Y, Song H, Xiong S, Tian T, Liu T, Sun Y.
    Int J Biol Macromol; 2018 Apr 01; 109():672-680. PubMed ID: 29288032
    [Abstract] [Full Text] [Related]

  • 20. Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies.
    Chadha R, Gupta S, Pathak N.
    Drug Dev Ind Pharm; 2012 Dec 01; 38(12):1538-46. PubMed ID: 22348223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.